Helen of Troy Limited Form 10-K Summary
Business Context and Reporting Period
Helen of Troy Limited is a Bermuda-based global consumer products company operating in four segments: Housewares, Health & Home, Nutritional Supplements, and Beauty. Products are sold in approximately 84 countries through retailers, distributors, e-commerce channels, and direct-to-consumer marketing. The filing reports the fiscal year ended February 29, 2016; the supplied metadata references 2015 Q4, but the filing is an annual FY2016 report.
Financial Performance and Position
| Metric | FY2016 | FY2015 | Change |
|---|---|---|---|
| Net sales | $1,545.7 million | $1,445.1 million | +7.0% |
| Gross profit / margin | $636.0 million / 41.1% | $599.6 million / 41.5% | Margin down 0.4 pts |
| Operating income / margin | $130.6 million / 8.5% | $161.7 million / 11.2% | Income down 19.2% |
| Net income | $101.2 million | $131.2 million | Down 22.8% |
| Diluted EPS | $3.52 | $4.52 | Down $1.00 |
| Adjusted diluted EPS | $6.25 | $5.85 | Up 6.8% |
| Operating cash flow | $185.3 million | $178.6 million | Up $6.7 million |
| Cash and equivalents | $225.8 million | $12.3 million | Up $213.5 million |
| Total debt | $623.9 million | $433.2 million | Up $190.7 million |
Sales growth included $60.9 million from acquisitions and $39.7 million of core-business growth. Segment sales were Housewares $310.7 million, Health & Home $642.7 million, Nutritional Supplements $153.1 million, and Beauty $439.2 million. Segment operating income was $56.7 million, $38.1 million, $11.4 million, and $24.4 million, respectively.
Liquidity improved principally because the Company drew approximately $210 million shortly before year-end to fund the subsequent Hydro Flask acquisition. Working capital was $504.0 million, with a 2.9:1 current ratio. The Company generated $185.3 million of operating cash flow, spent $20.6 million on capital and intangible assets, and used $63.7 million in investing activities. It repurchased $100 million of common stock during the year.
Material Changes Versus the Prior Comparable Period
- Housewares sales increased 4.9%, while operating income declined 4.6% because of promotional spending, advertising, capacity investments, and product mix.
- Health & Home sales increased 4.8%, but operating income declined 25.1%, primarily because of foreign exchange effects, the Exergen patent litigation charge, and the absence of a prior-year license amendment gain.
- Nutritional Supplements included a full year of Healthy Directions results compared with eight months in FY2015; comparable core sales for the overlapping period were approximately flat.
- Beauty sales increased only 0.9%, while operating income declined 41.8%, reflecting Venezuelan remeasurement charges, foreign exchange pressure, and restructuring-related costs.
- Internet-based customer sales grew approximately 16% and represented approximately 10% of consolidated sales, compared with 9% in FY2015.
- Reported sales were reduced by approximately $29.8 million by unfavorable foreign currency movements, while the prior year included a $7.0 million after-tax gain from a Honeywell trademark-license amendment.
Guidance, Outlook, Risks, and Unusual Items
- Management expected a FY2017 effective tax rate of approximately 13.0% to 15.0%.
- Management expected the weaker U.S. cough, cold, and flu season to pressure initial replenishment of Health & Home products in FY2017 because of elevated retail inventories.
- The Company expected Venezuelan U.S.-dollar sales and operating income to become immaterial after adopting the DICOM exchange rate.
- On March 18, 2016, after year-end, the Company acquired Hydro Flask for approximately $210 million in cash, funded with borrowings. Hydro Flask reported approximately $54 million of calendar-year 2015 revenue.
- FY2016 included $18.73 million of Venezuelan remeasurement-related charges, $17.83 million for Exergen thermometer patent litigation, $6.71 million of CEO succession costs, and $6.00 million of Beauty trademark impairment charges.
- The Exergen jury award was $14.6 million, and the Company may owe royalties on future sales of the affected products. The matter remained subject to post-trial motions and appeal.
- The Company relies heavily on large retailers, including approximately 16% of sales from Wal-Mart and 8% from Target; its top five customers represented approximately 40% of sales.
- Approximately 68% of finished goods purchases were sourced from Far East vendors, and approximately 73% of consolidated gross sales volume shipped through two northern Mississippi distribution facilities.
- Debt agreements imposed leverage, interest coverage, net worth, debt-incurrence, dividend, and share-repurchase restrictions. The Company reported $98.4 million of credit-facility availability but stated that covenant limitations effectively restricted additional debt capacity to approximately $64.3 million at year-end.
Most Important Facts for Investors to Verify
- Reconcile GAAP results with management’s adjusted income and EPS, particularly the treatment of Venezuelan charges, patent litigation, impairment, amortization, share compensation, and CEO succession costs.
- Assess post-acquisition leverage and liquidity after the $210 million Hydro Flask acquisition and related borrowing.
- Monitor the final outcome, potential royalties, and cash exposure from the Exergen patent litigation.
- Evaluate whether Beauty’s restructuring and new-product initiatives can reverse the segment’s declining operating profitability.
- Verify the sustainability of core organic growth after separating acquisition effects and foreign-exchange impacts.
- Review exposure to retailer concentration, Far East sourcing, distribution-center concentration, foreign currency volatility, and Venezuelan economic restrictions.
- Consider the significance of goodwill and intangible assets of approximately $958.8 million relative to total assets of $1.87 billion and the risk of future impairment.
- Confirm compliance with debt covenants and the availability of remaining share-repurchase authorization, reported at approximately $159.0 million.